Early Access — free while we kick the tires
EdgarHawk

SELICK HAROLD E

Director

Director
1 filing analyzed · 1 company · Latest 2026-03-27

Companies

Company Buys Sells Direction
Protagonist Therapeutics, Inc PTGX 0 2 Net selling

Activity

March 2026
high
Sell
24,000 shares
$2,520,000
Significance 6/10

Director Selick sells 24,000 PTGX shares at $105.00; stock down to $98.97, company burning $39.3M annually on $4.7M quarterly revenue.

Director Harold E Selick sold 24,000 shares (28.3% of his pre-transaction holdings) at $105.00 on 2026-03-26, executing at a price currently above the $98.97 market level but 5.1% below the 52-week high. The sale occurred in a company facing severe financial stress: annual revenue growth was -89.4%, net income was negative $39,339,000.00 in the most recent full fiscal year, and the latest quarter shows only $4,712,000.00 in revenue against continued operating losses. The director retained 60,845 shares post-transaction, maintaining a meaningful stake in the business. This sale represents a discrete reduction in an insider's position at a relatively elevated price point in the context of the company's deteriorating financial trajectory and depressed annual growth profile.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access